Adocia (EURONEXT:ADOC)

European company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - ADOC

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - ADOC

  • Market Cap€48.570m
  • SymbolEURONEXT:ADOC
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINFR0011184241

Company Profile

Adocia is a clinical-stage biotechnology company. It specializes in the development of formulations of already approved therapeutic proteins. The firm has developed Biochaperone proprietary technological platform to enhance the effectiveness of therapeutic proteins. The company's product pipeline includes biochaprone lispro, biochaparone combo, biochaparone human glucagon etc. Its patent portfolio mainly consists of chronic wound healing, insulin therapy, and monoclonal antibodies.Adocia is a biotechnological company. The Company is engaged in development of medicines for the treatment of diabetes from already-approved therapeutic molecules, in particular proteins, using its BioChaperone technology.

Latest ADOC news

Currently there for this company. Visit our news hub for other news .